QuantLogix's 5-factor engine currently reads iShares Biotechnology ETF (IBB) as a buy at 61/100 — a bullish setup. Technical is the strongest leg at 61/100, while fundamental lags at 50/100.
Updated · recomputed every few minutes while markets are open.
The score blends five independent reads of the fund — technical (trend and chart structure), momentum (rate of change across horizons), fundamental (valuation, growth and quality), options (positioning and implied volatility) and microstructure (order flow and liquidity) — into one number from 0 to 100. The weights adapt to the ticker; the bars above show the live weight of each factor.
| Score | Band |
|---|---|
| 70–100 | Strong Buy |
| 50–69 | Buy |
| 30–49 | Neutral |
| 16–29 | Sell |
| 0–15 | Strong Sell |
iShares Biotechnology ETF (IBB) reads Buy at 61 out of 100 on QuantLogix's 5-factor quant signal as of Oct 5, 2026, 4:25 AM ET — a bullish read. Technical is the strongest factor at 61/100 and fundamental is the weakest at 50/100.
QuantLogix's model currently classifies IBB as Buy (61/100). That is a quantitative reading of price, momentum, fundamentals, options and order flow — not a personal recommendation. It recomputes every few minutes, so re-check it before acting and weigh your own goals and risk.
The score is a weighted blend of five factors. For IBB the live weights are technical 46%, momentum 20%, options 4%, microstructure 30%. Fundamental is shown for context but not weighted for this ETF. Scores map to bands: Strong Buy 70–100, Buy 50–69, Neutral 30–49, Sell 16–29, Strong Sell 0–15.
Every QuantLogix signal is logged when it is issued and graded against the live market. Across 5,322 resolved signals the average return is +0.27% per signal. The full, audited record is public at quantlogix.ai/proof.
The signal recomputes every few minutes while markets are open, and this page refreshes within five minutes of each update. It is free to read with no account.
Live 5-factor quant signal — technical, momentum, fundamental, options, and microstructure — recomputed every few minutes. Educational market analysis, not investment advice. QuantLogix does not provide personalized recommendations. See the verified track record → · Browse all signal scorecards →